Biogen stock could pop Thursday after the biotech company beat first-quarter expectations, including strong sales for two newcomer drugs.
The post Biogen Easily Tops Earnings Forecasts As Leqembi, Skyclarys Sales Soar appeared first on Investor's Business Daily.